https://www.med-life.it/number_articles/tml-n-14-2025-repellenti-insetti/105_puntichiave/ 2025-06-30T05:58:07+00:00 https://www.med-life.it/number_articles/tml-n-14-2025-repellenti-insetti/107_tab_1/ 2025-06-30T06:04:56+00:00 https://www.med-life.it/number_articles/tml-n-14-2025-repellenti-insetti/108_desc_1/ 2025-06-30T06:06:23+00:00 https://www.med-life.it/number_articles/tml-n-14-2025-repellenti-insetti/108_desc_2_unite/ 2025-06-30T06:06:39+00:00 https://www.med-life.it/number_articles/tml-n-14-2025-un-test-del-sangue-la-malattia-alzheimer/109_puntichiave/ 2025-06-30T06:19:13+00:00 https://www.med-life.it/number_articles/tml-n-14-2025-un-test-del-sangue-la-malattia-alzheimer/109_desc/ 2025-06-30T06:20:26+00:00 https://www.med-life.it/number_articles/tml-n-14-2025-fitusiran-lemofilia-b/110_puntichiave/ 2025-06-30T06:33:28+00:00 https://www.med-life.it/number_articles/tml-n-14-2025-fitusiran-lemofilia-b/111_desc/ 2025-06-30T06:35:10+00:00 https://www.med-life.it/number_articles/tml-n-14-2025-dupilumab-lorticaria-cronica-spontanea/112_desc/ 2025-06-30T06:42:01+00:00 https://www.med-life.it/number_articles/tml-n-13-2025-protezioni-solari/102_desc_1_unite/ 2025-07-01T20:19:28+00:00 https://www.med-life.it/number_articles/tml-n-15-2025-berdazimer-gel-mollusco-contagioso/113_puntichiave/ 2025-07-18T05:37:40+00:00 https://www.med-life.it/number_articles/tml-n-15-2025-berdazimer-gel-mollusco-contagioso/114_desc/ 2025-07-18T05:38:32+00:00 https://www.med-life.it/number_articles/tml-n-15-2025-upadacitinib-larterite-cellule-giganti/115_puntichiave/ 2025-07-18T05:49:17+00:00 https://www.med-life.it/number_articles/tml-n-15-2025-upadacitinib-larterite-cellule-giganti/115_desc/ 2025-07-18T05:51:17+00:00 https://www.med-life.it/number_articles/tml-n-15-2025-un-dispositivo-lo-screening-domicilio-del-cancro-della-cervice/116_puntichiave/ 2025-07-18T05:59:32+00:00 https://www.med-life.it/number_articles/tml-n-15-2025-un-dispositivo-lo-screening-domicilio-del-cancro-della-cervice/116_desc/ 2025-07-18T06:00:51+00:00 https://www.med-life.it/number_articles/tml-n-15-2025-infusione-sottocutanea-apomorfina-la-malattia-parkinson/117_puntichiave/ 2025-07-18T06:06:29+00:00 https://www.med-life.it/number_articles/tml-n-15-2025-infusione-sottocutanea-apomorfina-la-malattia-parkinson/117_desc/ 2025-07-18T06:07:55+00:00 https://www.med-life.it/number_articles/tml-n-15-2025-clortalidone-basso-dosaggio-lipertensione/118_desc/ 2025-07-18T06:14:08+00:00 https://www.med-life.it/number_articles/tml-n-15-2025-approvazione-completa-vaccino-novavax-la-covid-19/118_desc_2/ 2025-07-18T06:18:12+00:00 https://www.med-life.it/number_articles/tml-n-15-2025-vaccini-mrna-la-covid-19-miocardite/119_desc/ 2025-07-18T06:21:30+00:00 https://www.med-life.it/number_articles/tml-n-15-2025-un-vaccino-mrna-moderna-la-covid-19/120_desc_unitee/ 2025-07-18T06:25:42+00:00 https://www.med-life.it/number_articles/tml-n-16-2025-farmaci-dispositivi-controllo-del-peso/121_insintesi/ 2025-07-28T21:03:17+00:00 https://www.med-life.it/number_articles/tml-n-16-2025-farmaci-dispositivi-controllo-del-peso/123_tab_1/ 2025-07-28T21:06:10+00:00 https://www.med-life.it/number_articles/tml-n-16-2025-farmaci-dispositivi-controllo-del-peso/124_tab_2/ 2025-07-28T21:07:42+00:00 https://www.med-life.it/number_articles/tml-n-16-2025-farmaci-dispositivi-controllo-del-peso/125_tab_2/ 2025-07-28T21:09:27+00:00 https://www.med-life.it/number_articles/tml-n-16-2025-farmaci-dispositivi-controllo-del-peso/127_contenutiaggiuntivi/ 2025-07-28T21:14:38+00:00 https://www.med-life.it/number_articles/tml-n-16-2025-farmaci-dispositivi-controllo-del-peso/ultima_contenutiaggiuntivi/ 2025-07-28T21:15:20+00:00 https://www.med-life.it/number_articles/tml-n-16-2025-farmaci-dispositivi-controllo-del-peso/127_desc_1/ 2025-07-28T21:16:00+00:00 https://www.med-life.it/number_articles/tml-n-16-2025-farmaci-dispositivi-controllo-del-peso/127_desc_2/ 2025-07-28T21:16:17+00:00 https://www.med-life.it/number_articles/tml-n-16-2025-farmaci-dispositivi-controllo-del-peso/ultima_desc_1/ 2025-07-28T21:17:15+00:00 https://www.med-life.it/number_articles/tml-n-16-2025-farmaci-dispositivi-controllo-del-peso/ultima_desc_2/ 2025-07-28T21:17:32+00:00 https://www.med-life.it/number_articles/ad-n-2852025-effetti-aritmogeni-degli-inibitori-della-tirosinchinasi-revisione-narrativa/1175_tab_1/ 2025-08-03T17:14:17+00:00 https://www.med-life.it/number_articles/ad-n-2852025-effetti-aritmogeni-degli-inibitori-della-tirosinchinasi-revisione-narrativa/1176_tab_2/ 2025-08-03T17:18:11+00:00 https://www.med-life.it/number_articles/ad-n-2852025-effetti-aritmogeni-degli-inibitori-della-tirosinchinasi-revisione-narrativa/1177_img/ 2025-08-03T17:18:30+00:00 https://www.med-life.it/number_articles/ad-n-2852025-effetti-aritmogeni-degli-inibitori-della-tirosinchinasi-revisione-narrativa/screenshot-2025-08-03-alle-19-19-26/ 2025-08-03T17:19:54+00:00 https://www.med-life.it/number_articles/ad-n-2852025-effetti-aritmogeni-degli-inibitori-della-tirosinchinasi-revisione-narrativa/ad-285-biblio-1/ 2025-08-03T17:25:54+00:00 https://www.med-life.it/number_articles/ad-n-2852025-effetti-aritmogeni-degli-inibitori-della-tirosinchinasi-revisione-narrativa/ad-285-biblio-2/ 2025-08-03T17:26:20+00:00 https://www.med-life.it/number_articles/ad-n-2852025-effetti-aritmogeni-degli-inibitori-della-tirosinchinasi-revisione-narrativa/ad-285-biblio-3/ 2025-08-03T17:26:39+00:00 https://www.med-life.it/number_articles/tml-n-17-2025-clesrovimab-la-prevenzione-delle-infezioni-gravi-rsv-nei-neonati/129_puntichiave/ 2025-08-05T08:05:51+00:00 https://www.med-life.it/number_articles/tml-n-17-2025-clesrovimab-la-prevenzione-delle-infezioni-gravi-rsv-nei-neonati/130_tab_1/ 2025-08-05T08:07:13+00:00 https://www.med-life.it/number_articles/tml-n-17-2025-clesrovimab-la-prevenzione-delle-infezioni-gravi-rsv-nei-neonati/130_tab_2/ 2025-08-05T08:13:25+00:00 https://www.med-life.it/number_articles/tml-n-17-2025-clesrovimab-la-prevenzione-delle-infezioni-gravi-rsv-nei-neonati/131_desc/ 2025-08-05T08:15:06+00:00 https://www.med-life.it/number_articles/tml-n-17-2025-mepolizumab-la-bpco/131_tab_1/ 2025-08-05T08:23:32+00:00 https://www.med-life.it/number_articles/tml-n-17-2025-mepolizumab-la-bpco/131_puntichiave/ 2025-08-05T08:25:14+00:00 https://www.med-life.it/number_articles/tml-n-17-2025-mepolizumab-la-bpco/132_tab_2/ 2025-08-05T08:25:59+00:00 https://www.med-life.it/number_articles/tml-n-17-2025-mepolizumab-la-bpco/132_desc/ 2025-08-05T08:27:59+00:00 https://www.med-life.it/number_articles/tml-n-17-2025-lenacapavir-la-profilassi-pre-esposizione-allhiv/133_tab_1/ 2025-08-05T08:33:22+00:00 https://www.med-life.it/number_articles/tml-n-17-2025-lenacapavir-la-profilassi-pre-esposizione-allhiv/133_puntichiave/ 2025-08-05T08:34:59+00:00 https://www.med-life.it/number_articles/tml-n-17-2025-lenacapavir-la-profilassi-pre-esposizione-allhiv/134_desc_1/ 2025-08-05T08:36:48+00:00 https://www.med-life.it/number_articles/tml-n-17-2025-un-schema-posologico-donanemab-morbo-alzheimer/134_desc_2/ 2025-08-05T08:44:16+00:00 https://www.med-life.it/number_articles/tml-n-17-2025-prurito-la-sospensione-degli-antistaminici/135_desc_1/ 2025-08-05T08:47:12+00:00 https://www.med-life.it/number_articles/tml-n-17-2025-nuova-avvertenza-gli-stimolanti-rilascio-prolungato-ladhd/135_desc_2/ 2025-08-05T08:50:57+00:00 https://www.med-life.it/number_articles/tml-n-17-2025-ipertermia-cerotti-alla-scopolamina/screenshot-2025-08-05-alle-10-53-37/ 2025-08-05T08:54:00+00:00 https://www.med-life.it/number_articles/tml-n-18-2025-farmaci-ladhd/137_puntichiave/ 2025-09-10T21:39:54+00:00 https://www.med-life.it/number_articles/tml-n-18-2025-farmaci-ladhd/140_tab_1/ 2025-09-10T21:43:36+00:00 https://www.med-life.it/number_articles/tml-n-18-2025-farmaci-ladhd/141_tab_1/ 2025-09-10T21:43:45+00:00 https://www.med-life.it/number_articles/tml-n-18-2025-farmaci-ladhd/142_desc/ 2025-09-10T21:48:03+00:00 https://www.med-life.it/number_articles/tml-n-18-2025-farmaci-ladhd/143_desc/ 2025-09-10T21:48:21+00:00 https://www.med-life.it/number_articles/tml-n-19-2025-acoltremon-la-sindrome-dellocchio-secco/145_puntichiave/ 2025-09-16T21:41:39+00:00 https://www.med-life.it/number_articles/tml-n-19-2025-acoltremon-la-sindrome-dellocchio-secco/146_tab_1/ 2025-09-16T21:42:34+00:00 https://www.med-life.it/number_articles/tml-n-19-2025-acoltremon-la-sindrome-dellocchio-secco/146_desc/ 2025-09-16T21:44:28+00:00 https://www.med-life.it/number_articles/tml-n-19-2025-nuova-indicazione-finerenone-nel-trattamento-dellinsufficienza-cardiaca/147_puntichiave/ 2025-09-16T21:50:13+00:00 https://www.med-life.it/number_articles/tml-n-19-2025-nuova-indicazione-finerenone-nel-trattamento-dellinsufficienza-cardiaca/147_desc/ 2025-09-16T21:52:15+00:00 https://www.med-life.it/number_articles/tml-n-19-2025-inclisiran-monoterapia-la-riduzione-del-colesterolo-ldl/148_tab_1/ 2025-09-16T22:22:07+00:00 https://www.med-life.it/number_articles/tml-n-19-2025-inclisiran-monoterapia-la-riduzione-del-colesterolo-ldl/149_desc/ 2025-09-16T22:23:22+00:00 https://www.med-life.it/number_articles/tml-n-19-2025-ceftobiprolo-medocaril-nuova-cefalosporina/150_tab_1/ 2025-09-16T22:28:04+00:00 https://www.med-life.it/number_articles/tml-n-19-2025-ceftobiprolo-medocaril-nuova-cefalosporina/151_puntichiave/ 2025-09-16T22:30:22+00:00 https://www.med-life.it/number_articles/tml-n-19-2025-ceftobiprolo-medocaril-nuova-cefalosporina/150_tab_2/ 2025-09-16T22:31:29+00:00 https://www.med-life.it/number_articles/tml-n-19-2025-ceftobiprolo-medocaril-nuova-cefalosporina/151_desc/ 2025-09-16T22:32:41+00:00 https://www.med-life.it/number_articles/tml-n-19-2025-ceftobiprolo-medocaril-nuova-cefalosporina/151_tab_3/ 2025-09-16T22:36:38+00:00 https://www.med-life.it/number_articles/tml-n-19-2025-revoca-del-rems-embriotossicita-negli-antagonisti-dei-recettori-dellendotelina/152_desc/ 2025-09-16T22:47:34+00:00 https://www.med-life.it/number_articles/ad-n-2862025-reazioni-avverse-nei-neonati-ai-farmaci-presenti-nel-latte-materno-segnalate-allagenzia-danese-medicinali-dal-2013-al-2023/1182_tab_1/ 2025-09-22T20:40:10+00:00 https://www.med-life.it/number_articles/ad-n-2862025-reazioni-avverse-nei-neonati-ai-farmaci-presenti-nel-latte-materno-segnalate-allagenzia-danese-medicinali-dal-2013-al-2023/1182_tab_2/ 2025-09-22T20:42:42+00:00 https://www.med-life.it/number_articles/ad-n-2862025-reazioni-avverse-nei-neonati-ai-farmaci-presenti-nel-latte-materno-segnalate-allagenzia-danese-medicinali-dal-2013-al-2023/1182_tab_3/ 2025-09-22T20:42:54+00:00 https://www.med-life.it/number_articles/ad-n-2862025-reazioni-avverse-nei-neonati-ai-farmaci-presenti-nel-latte-materno-segnalate-allagenzia-danese-medicinali-dal-2013-al-2023/biblio-3/ 2025-09-22T20:47:17+00:00 https://www.med-life.it/number_articles/ad-n-2862025-reazioni-avverse-nei-neonati-ai-farmaci-presenti-nel-latte-materno-segnalate-allagenzia-danese-medicinali-dal-2013-al-2023/biblio_2-4/ 2025-09-22T20:47:31+00:00 https://www.med-life.it/number_articles/ad-n-2862025-reazioni-avverse-nei-neonati-ai-farmaci-presenti-nel-latte-materno-segnalate-allagenzia-danese-medicinali-dal-2013-al-2023/biblio_3-2/ 2025-09-22T20:47:53+00:00 https://www.med-life.it/number_articles/tml-n-20-2025-vaccini-antinfluenzali-la-stagione-2025-2026/153_punti/ 2025-09-30T20:49:26+00:00 https://www.med-life.it/number_articles/tml-n-20-2025-vaccini-antinfluenzali-la-stagione-2025-2026/153_tab_1/ 2025-09-30T20:49:43+00:00 https://www.med-life.it/number_articles/tml-n-20-2025-vaccini-antinfluenzali-la-stagione-2025-2026/155_tab_2/ 2025-09-30T20:53:58+00:00 https://www.med-life.it/number_articles/tml-n-20-2025-vaccini-antinfluenzali-la-stagione-2025-2026/156_desc/ 2025-09-30T20:56:53+00:00 https://www.med-life.it/number_articles/tml-n-20-2025-vaccini-antinfluenzali-la-stagione-2025-2026/157_desc/ 2025-09-30T20:57:09+00:00 https://www.med-life.it/number_articles/tml-n-20-2025-ritorno-del-meloxicam-ev-trattamento-del-dolore/158_punti/ 2025-09-30T21:14:43+00:00 https://www.med-life.it/number_articles/tml-n-20-2025-ritorno-del-meloxicam-ev-trattamento-del-dolore/159_tab_1/ 2025-09-30T21:16:00+00:00 https://www.med-life.it/number_articles/tml-n-20-2025-ritorno-del-meloxicam-ev-trattamento-del-dolore/desc_1/ 2025-09-30T21:17:57+00:00 https://www.med-life.it/number_articles/tml-n-20-2025-ritorno-del-meloxicam-ev-trattamento-del-dolore/desc_2/ 2025-09-30T21:18:25+00:00 https://www.med-life.it/number_articles/tml-n-21-2025-semaglutide-la-mash/161_punti/ 2025-10-05T15:30:01+00:00 https://www.med-life.it/number_articles/tml-n-21-2025-semaglutide-la-mash/162_tab_1/ 2025-10-05T15:30:18+00:00 https://www.med-life.it/number_articles/tml-n-21-2025-semaglutide-la-mash/162_tab_2/ 2025-10-05T15:32:08+00:00 https://www.med-life.it/number_articles/tml-n-21-2025-semaglutide-la-mash/162_desc/ 2025-10-05T15:33:02+00:00 https://www.med-life.it/number_articles/tml-n-21-2025-semaglutide-la-mash/163_desc/ 2025-10-05T15:33:23+00:00 https://www.med-life.it/number_articles/tml-n-21-2025-delgocitinib-crema-leczema-cronico-delle-mani/163_punti/ 2025-10-05T15:42:23+00:00 https://www.med-life.it/number_articles/tml-n-21-2025-delgocitinib-crema-leczema-cronico-delle-mani/163_tab_1/ 2025-10-05T15:42:38+00:00 https://www.med-life.it/number_articles/tml-n-21-2025-delgocitinib-crema-leczema-cronico-delle-mani/164_tab_2/ 2025-10-05T15:43:52+00:00 https://www.med-life.it/number_articles/tml-n-21-2025-delgocitinib-crema-leczema-cronico-delle-mani/165_desc/ 2025-10-05T15:46:11+00:00 https://www.med-life.it/number_articles/tml-n-21-2025-laggiunta-pramipexolo-la-depressione-resistente-al-trattamento/165_tab_1/ 2025-10-05T15:58:46+00:00 https://www.med-life.it/number_articles/tml-n-21-2025-laggiunta-pramipexolo-la-depressione-resistente-al-trattamento/166_desc/ 2025-10-05T16:00:00+00:00 https://www.med-life.it/number_articles/tml-n-21-2025-formulazioni-raccomandazioni-relative-al-vaccino-2025-2026/166_tab_1/ 2025-10-05T16:06:23+00:00 https://www.med-life.it/number_articles/tml-n-21-2025-formulazioni-raccomandazioni-relative-al-vaccino-2025-2026/167_tab_2/ 2025-10-05T16:06:37+00:00 https://www.med-life.it/number_articles/tml-n-21-2025-formulazioni-raccomandazioni-relative-al-vaccino-2025-2026/168_desc_1/ 2025-10-05T16:08:49+00:00 https://www.med-life.it/number_articles/tml-n-21-2025-formulazioni-raccomandazioni-relative-al-vaccino-2025-2026/168_desc_2/ 2025-10-05T16:09:04+00:00 https://www.med-life.it/number_articles/tml-n-22-2025-farmaci-antivirali-linfluenza-stagionale-2025-2026/169_tab_1/ 2025-10-21T21:10:29+00:00 https://www.med-life.it/number_articles/tml-n-22-2025-farmaci-antivirali-linfluenza-stagionale-2025-2026/169_punti_chiave/ 2025-10-21T21:11:17+00:00 https://www.med-life.it/number_articles/tml-n-22-2025-farmaci-antivirali-linfluenza-stagionale-2025-2026/171_tab_2/ 2025-10-21T21:13:42+00:00 https://www.med-life.it/number_articles/tml-n-22-2025-farmaci-antivirali-linfluenza-stagionale-2025-2026/173_desc_1/ 2025-10-21T21:16:32+00:00 https://www.med-life.it/number_articles/tml-n-22-2025-farmaci-antivirali-linfluenza-stagionale-2025-2026/173_desc_2/ 2025-10-21T21:16:45+00:00 https://www.med-life.it/number_articles/tml-n-22-2025-farmaci-antivirali-linfluenza-stagionale-2025-2026/174_desc_1/ 2025-10-21T21:17:09+00:00 https://www.med-life.it/number_articles/tml-n-22-2025-farmaci-antivirali-linfluenza-stagionale-2025-2026/174_desc_2/ 2025-10-21T21:17:23+00:00 https://www.med-life.it/number_articles/tml-n-22-2025-deuruxolitinib-lalopecia-areata-grave/175_tab_1/ 2025-10-21T21:33:08+00:00 https://www.med-life.it/number_articles/tml-n-22-2025-deuruxolitinib-lalopecia-areata-grave/175_tab_2/ 2025-10-21T21:33:20+00:00 https://www.med-life.it/number_articles/tml-n-22-2025-deuruxolitinib-lalopecia-areata-grave/175_tab_3/ 2025-10-21T21:34:45+00:00 https://www.med-life.it/number_articles/tml-n-22-2025-deuruxolitinib-lalopecia-areata-grave/ultima_desc_1-2/ 2025-10-21T21:36:22+00:00 https://www.med-life.it/number_articles/tml-n-22-2025-deuruxolitinib-lalopecia-areata-grave/ultima_desc_2-2/ 2025-10-21T21:36:36+00:00 https://www.med-life.it/number_articles/ad-n-2872025-quanto-pericolosa-la-noce-moscata/1186_tab_1/ 2025-10-22T21:13:23+00:00 https://www.med-life.it/number_articles/ad-n-2872025-quanto-pericolosa-la-noce-moscata/1187_schema/ 2025-10-22T21:13:40+00:00 https://www.med-life.it/number_articles/ad-n-2872025-quanto-pericolosa-la-noce-moscata/1188_tab_2/ 2025-10-22T21:15:28+00:00 https://www.med-life.it/number_articles/ad-n-2872025-quanto-pericolosa-la-noce-moscata/ad-287-biblio/ 2025-10-22T21:19:17+00:00 https://www.med-life.it/number_articles/tml-n-23-2025-aceclidina-la-presbiopia/177_punti_chiave/ 2025-11-16T23:40:09+00:00 https://www.med-life.it/number_articles/tml-n-23-2025-aceclidina-la-presbiopia/178_tab_1/ 2025-11-16T23:41:56+00:00 https://www.med-life.it/number_articles/tml-n-23-2025-aceclidina-la-presbiopia/178_desc/ 2025-11-16T23:43:07+00:00 https://www.med-life.it/number_articles/tml-n-23-2025-aceclidina-la-presbiopia/178_tab_1-2/ 2025-11-16T23:45:59+00:00 https://www.med-life.it/number_articles/tml-n-23-2025-aceclidina-la-presbiopia/178_desc-2/ 2025-11-16T23:46:32+00:00 https://www.med-life.it/number_articles/tml-n-23-2025-sulopenem-etzadroxilprobenecid-le-infezioni-non-complicate-delle-vie-urinarie/179_punti_chiave/ 2025-11-16T23:56:35+00:00 https://www.med-life.it/number_articles/tml-n-23-2025-sulopenem-etzadroxilprobenecid-le-infezioni-non-complicate-delle-vie-urinarie/179_tab_1/ 2025-11-16T23:57:44+00:00 https://www.med-life.it/number_articles/tml-n-23-2025-sulopenem-etzadroxilprobenecid-le-infezioni-non-complicate-delle-vie-urinarie/180_desc_1/ 2025-11-16T23:59:28+00:00 https://www.med-life.it/number_articles/tml-n-23-2025-sulopenem-etzadroxilprobenecid-le-infezioni-non-complicate-delle-vie-urinarie/180_desc_2/ 2025-11-17T00:00:10+00:00 https://www.med-life.it/number_articles/tml-n-23-2025-garadacimab-la-profilassi-dellangioedema-ereditario/180_tab_1/ 2025-11-17T00:09:58+00:00 https://www.med-life.it/number_articles/tml-n-23-2025-garadacimab-la-profilassi-dellangioedema-ereditario/181_punti_chiave/ 2025-11-17T00:11:07+00:00 https://www.med-life.it/number_articles/tml-n-23-2025-garadacimab-la-profilassi-dellangioedema-ereditario/181_tab_2/ 2025-11-17T00:12:56+00:00 https://www.med-life.it/number_articles/tml-n-23-2025-garadacimab-la-profilassi-dellangioedema-ereditario/182_desc/ 2025-11-17T00:13:45+00:00 https://www.med-life.it/number_articles/tml-n-23-2025-aggiornamenti-sul-lecanemab-la-malattia-alzheimer/182_tab_1/ 2025-11-17T00:21:38+00:00 https://www.med-life.it/number_articles/tml-n-23-2025-aggiornamenti-sul-lecanemab-la-malattia-alzheimer/183_desc_1/ 2025-11-17T00:22:44+00:00 https://www.med-life.it/number_articles/tml-n-23-2025-screening-laldosteronismo-primario-pazienti-ipertensione/183_tab_1/ 2025-11-17T00:28:04+00:00 https://www.med-life.it/number_articles/tml-n-23-2025-screening-laldosteronismo-primario-pazienti-ipertensione/183_desc_2/ 2025-11-17T00:29:16+00:00 https://www.med-life.it/?attachment_id=33420 2025-11-21T08:22:42+00:00 https://www.med-life.it/number_articles/tml-n-24-2025-farmaci-non-insulinici-diabete-tipo-2/185_acronimi/ 2025-11-23T15:42:05+00:00 https://www.med-life.it/number_articles/tml-n-24-2025-farmaci-non-insulinici-diabete-tipo-2/185_puntichiave/ 2025-11-23T15:43:23+00:00 https://www.med-life.it/number_articles/tml-n-24-2025-farmaci-non-insulinici-diabete-tipo-2/186_tab_1/ 2025-11-23T15:44:21+00:00 https://www.med-life.it/number_articles/tml-n-24-2025-farmaci-non-insulinici-diabete-tipo-2/186_tab_2/ 2025-11-23T15:45:22+00:00 https://www.med-life.it/number_articles/tml-n-24-2025-farmaci-non-insulinici-diabete-tipo-2/187_tab_3/ 2025-11-23T15:46:35+00:00 https://www.med-life.it/number_articles/tml-n-24-2025-farmaci-non-insulinici-diabete-tipo-2/188_tab_4/ 2025-11-23T15:48:29+00:00 https://www.med-life.it/number_articles/tml-n-24-2025-farmaci-non-insulinici-diabete-tipo-2/189_tab_4/ 2025-11-23T15:48:48+00:00 https://www.med-life.it/number_articles/tml-n-24-2025-farmaci-non-insulinici-diabete-tipo-2/190_tab_5/ 2025-11-23T15:50:15+00:00 https://www.med-life.it/number_articles/tml-n-24-2025-farmaci-non-insulinici-diabete-tipo-2/191_tab_6/ 2025-11-23T15:51:37+00:00 https://www.med-life.it/number_articles/tml-n-24-2025-farmaci-non-insulinici-diabete-tipo-2/192_desc/ 2025-11-23T15:53:11+00:00 https://www.med-life.it/number_articles/tml-n-25-2025-autismo-uso-prenatale-paracetamolo/pag_193_inbreve/ 2025-12-08T22:44:24+00:00 https://www.med-life.it/number_articles/tml-n-25-2025-autismo-uso-prenatale-paracetamolo/195_desc_1/ 2025-12-08T22:46:57+00:00 https://www.med-life.it/number_articles/tml-n-25-2025-autismo-uso-prenatale-paracetamolo/195_desc_2/ 2025-12-08T22:47:17+00:00 https://www.med-life.it/number_articles/tml-n-25-2025-unindicazione-cardiovascolare-la-semaglutide-orale/196_tab_1/ 2025-12-08T23:29:12+00:00 https://www.med-life.it/number_articles/tml-n-25-2025-unindicazione-cardiovascolare-la-semaglutide-orale/196_cont_desc/ 2025-12-08T23:30:39+00:00 https://www.med-life.it/number_articles/tml-n-25-2025-insuline-diabete-tipo-2/197_puntichiave/ 2025-12-08T23:36:02+00:00 https://www.med-life.it/number_articles/tml-n-25-2025-insuline-diabete-tipo-2/198_tab_1/ 2025-12-08T23:38:10+00:00 https://www.med-life.it/number_articles/tml-n-25-2025-insuline-diabete-tipo-2/199_cont_agg/ 2025-12-08T23:39:48+00:00 https://www.med-life.it/number_articles/tml-n-25-2025-insuline-diabete-tipo-2/198_desc/ 2025-12-08T23:40:30+00:00 https://www.med-life.it/number_articles/tml-n-25-2025-insuline-diabete-tipo-2/199_ult/ 2025-12-08T23:41:24+00:00 https://www.med-life.it/number_articles/tml-n-26-2025-estensione-delle-indicazioni-gli-inibitori-della-pcsk9/201_comunicazione/ 2025-12-27T16:39:20+00:00 https://www.med-life.it/number_articles/tml-n-26-2025-estensione-delle-indicazioni-gli-inibitori-della-pcsk9/201_puntichiave/ 2025-12-27T16:40:27+00:00 https://www.med-life.it/number_articles/tml-n-26-2025-estensione-delle-indicazioni-gli-inibitori-della-pcsk9/202_tab_1-2/ 2025-12-27T16:41:35+00:00 https://www.med-life.it/number_articles/tml-n-26-2025-estensione-delle-indicazioni-gli-inibitori-della-pcsk9/203_desc/ 2025-12-27T16:43:14+00:00 https://www.med-life.it/number_articles/tml-n-26-2025-elinzanetant-sintomi-vasomotori-della-menopausa/204_tab_1-2/ 2025-12-27T16:52:17+00:00 https://www.med-life.it/number_articles/tml-n-26-2025-elinzanetant-sintomi-vasomotori-della-menopausa/204_tab_2/ 2025-12-27T16:53:37+00:00 https://www.med-life.it/number_articles/tml-n-26-2025-elinzanetant-sintomi-vasomotori-della-menopausa/204_tab_3/ 2025-12-27T16:53:48+00:00 https://www.med-life.it/number_articles/tml-n-26-2025-elinzanetant-sintomi-vasomotori-della-menopausa/205_puntichiave/ 2025-12-27T16:55:26+00:00 https://www.med-life.it/number_articles/tml-n-26-2025-elinzanetant-sintomi-vasomotori-della-menopausa/205_desc/ 2025-12-27T16:58:34+00:00 https://www.med-life.it/number_articles/tml-n-26-2025-autoiniettore-diidroergotamina-lemicrania/206_puntichiave-2/ 2025-12-27T17:08:04+00:00 https://www.med-life.it/number_articles/tml-n-26-2025-autoiniettore-diidroergotamina-lemicrania/206_desc/ 2025-12-27T17:09:04+00:00 https://www.med-life.it/number_articles/tml-n-26-2025-nerandomilast-la-fibrosi-polmonare-idiopatica/207_tab_1-2/ 2025-12-27T17:17:56+00:00 https://www.med-life.it/number_articles/tml-n-26-2025-nerandomilast-la-fibrosi-polmonare-idiopatica/207_puntichiave-2/ 2025-12-27T17:18:37+00:00 https://www.med-life.it/number_articles/tml-n-26-2025-nerandomilast-la-fibrosi-polmonare-idiopatica/207_desc-2/ 2025-12-27T17:19:58+00:00 https://www.med-life.it/number_articles/tml-n-26-2025-nerandomilast-la-fibrosi-polmonare-idiopatica/208_ultima/ 2025-12-27T17:20:43+00:00 https://www.med-life.it/number_articles/ad-n-2882025-prove-dellototossicita-dei-farmaci-commercializzati-danimarca/1191_grafico/ 2025-12-27T17:27:56+00:00 https://www.med-life.it/number_articles/ad-n-2882025-prove-dellototossicita-dei-farmaci-commercializzati-danimarca/1193_tab_1/ 2025-12-27T17:30:36+00:00 https://www.med-life.it/number_articles/ad-n-2882025-prove-dellototossicita-dei-farmaci-commercializzati-danimarca/1194_bibliografia/ 2025-12-27T17:32:06+00:00 https://www.med-life.it/number_articles/ad-n-2882025-prove-dellototossicita-dei-farmaci-commercializzati-danimarca/1194_bibliografia_2/ 2025-12-27T17:32:43+00:00 https://www.med-life.it/number_articles/ad-n-2882025-prove-dellototossicita-dei-farmaci-commercializzati-danimarca/1195_lettera/ 2025-12-27T17:33:19+00:00